Professor Catriona Bradshaw [MD, PhD] is a clinician researcher and Head of Research Translation and Mentorship and of The Genital Microbiota and Mycoplasma Group at Melbourne Sexual Health Centre, Central Clinical School, Monash University and Alfred Hospital. Her programme focuses on translational research to improve treatment & control of STIs, particularly Mycoplasma genitalium, an STI which has developed resistance to available therapies, and bacterial vaginosis (BV), a common dysbiosis that is refractory to current treatment and associated with adverse reproductive and sexual health outcomes. She has >15 years’ experience in clinical and epidemiological research on BV and the vaginal microbiota. Her group undertakes RCTs and large prospective studies to understand the pathogenesis of BV and develop interventions to improve cure and restore a vaginal microbiota associated with optimal reproductive health. Her group is currently undertaking an NHMRC funded multicentre male partner treatment trial for women with BV to determine if partner treatment improves BV cure. Catriona’s group is part of the EVE-M consortium to develop multipurpose prevention technologies to improve sexual and reproductive health for women. She is a Centre Head for the Centre to Impact Antimicrobial Resistance (Monash University), and a Co-director of the ARC Research Hub to combat Antimicrobial Resistance (University of NSW), which has a focus on new diagnostics and antimicrobials to combat STIs. Catriona has a strong track record of translating findings into policy and practice with >300 publications She has been a member of national and international STI guideline committees, a board member of the International Society for STD Research and a recipient of a L'Oréal-UNESCO Women in Science Award.
